“Fumarate attenuated doxorubicin-induced cardiac injury through modulation of endothelial nitric oxide synthase expression and transforming growth factor-β1 signaling” (2025) Prospects in Pharmaceutical Sciences, 24(2), pp. 52–59. doi:10.56782/pps.677.